💊Small Molecule Drugs
Traditional chemically synthesized drugs that can be taken orally. Includes blockbusters like statins, antivirals, and kinase inhibitors.
Market Cap$4.5T
1D-1.25%
Companies2,108
Public Cos365
SECTOR MARKET CAP
$4.5T+339.6%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | United States | $851.4B | LLY |
| 2 |  | United States | $355.2B | ABBV |
| 3 |  | United Kingdom | $282.1B | AZN |
| 4 |  | Switzerland | $278.1B | NVS |
| 5 |  | Switzerland | $219.3B | ROG.SW |
| 6 |  | United States | $177.9B | AMGN |
| 7 |  | United Kingdom | $165.6B | APH |
| 8 |  | United States | $163.2B | GILD |
| 9 |  | United States | $147.6B | PFE |
| 10 |  | United States | $114.0B | BMY |
| 11 |  | United States | $108.9B | VRTX |
| 12 |  | France | $102.8B | SNY |
| 13 |  | United Kingdom | $100.7B | GSK |
| 14 |  | United States | $74.6B | REGN |
| 15 |  | United States | $52.3B | TAK |
| 16 |  | China | $51.5B | 600276.SS |
| 17 |  | India | $46.9B | SUNPHARMA.NS |
| 18 |  | Germany | $43.2B | BAYN.DE |
| 19 |  | Israel | $41.8B | TEVA |
| 20 |  | Switzerland | $37.5B | SDZ.SW |